Injective (INJ) price prediction: Is $18.80 the key level for bullish trades?
Injective has exhibited notable price movements over the past year. In November, the asset underwent a significant consolidation between $15.24 and $18.80. This phase was a precursor to a substantial 210% upward expansion in December, underscoring the importance of the $18.80 level as a pivotal "scene of the crime" price point.
Over the last 240 days, Injective's price action has been characterised by choppy sideways movements, transitioning into more bearish patterns influenced by negative market sentiment and overarching narratives.
Key observations pivotal price point at $18.80:
This level has been instrumental for executing minor upside trades, proving especially favorable for buy-side strategies.
Recent market structure:
The asset is currently trading below the $18.80 mark, primarily due to the Japanese yen trade unwind. A descending channel or flag pattern has formed, indicated by established support and horizontal trend lines. This corrective formation suggests sustained demand for Injective, even amidst bearish conditions
Disclaimer: This is not financial or investment advice. You are responsible for any capital-related decisions you make, and only you are accountable for the results.
Support floor at $16:
The market has identified a support level around $16, serving as a critical foundation for assessing forthcoming strategic moves. Potential Scenarios:
Bullish scenario
Spot Position Building: Investors might consider accumulating positions within the "yellow box" zone, corresponding to the previous consolidation range of $15.24 to $18.80. Given Injective's historical performance, utility, and prospective growth, this area appears undervalued. Leverage Strategy: For those inclined towards higher risk, leveraging positions with stringent risk management (such as setting stop losses) is an option. However, it's prudent to await a decisive reclaim above the $18.80 level before initiating leveraged trades, as this would indicate a potential resurgence into the bullish territory that has been profitable in the past.
Bearish scenario
If the asset fails to maintain the $16 support, further downside could be anticipated. In such a case, reevaluating entry points and waiting for clearer bullish signals would be advisable.
Conclusion
The $18.80 price point remains a key price point in strategizing for Injective. Whether you opt for building spot positions within the established consolidation zone or wait for a bullish breakout for leveraged strategies, monitoring market behavior around these critical levels is essential.
Recommended from Cryptonary
